Harmines inhibit cancer cell growth through coordinated activation of apoptosis and inhibition of autophagy.

ABSTRACT: Harmine and its analogs have long been considered as anticancer agents. In vitro analyses suggested that intercalating DNA or inhibiting topoisomerase might contribute to the cytotoxic effect of this class of compound. However, this idea has not been rigorously tested in intact cells. By synthesizing novel derivatives, here we demonstrate that harmines did not activate the DNA damage response, a cellular signaling commonly induced by agents that intercalate DNA or inhibit topoisomerase. These findings suggest that mechanisms other than DNA intercalating or topoisomerase inhibiting contribute to the toxicity of harmines in vivo. Using a novel N²-benzyl and N⁹-arylated alkyl compound 10f that has good solubility and stability as the model, we show that harmines strongly

SUBMITTER: Geng X 

PROVIDER: S-EPMC5857254 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature